Auayporn Nademanee

Auayporn Nademanee

UNVERIFIED PROFILE

Are you Auayporn Nademanee?   Register this Author

Register author
Auayporn Nademanee

Auayporn Nademanee

Publications by authors named "Auayporn Nademanee"

Are you Auayporn Nademanee?   Register this Author

93Publications

2403Reads

43Profile Views

Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma.

Biol Blood Marrow Transplant 2019 Dec 5;25(12):2383-2387. Epub 2019 Aug 5.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Medical Oncology Division, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.07.041DOI Listing
December 2019

Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis.

Biol Blood Marrow Transplant 2019 02 15;25(2):287-292. Epub 2018 Sep 15.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183056
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502508PMC
February 2019

Safety Analysis of Brentuximab Vedotin from the Phase III AETHERA Trial in Hodgkin Lymphoma in the Post-Transplant Consolidation Setting.

Biol Blood Marrow Transplant 2018 11 30;24(11):2354-2359. Epub 2018 May 30.

Department of Hematology and Blood and Marrow Transplant, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.05.026DOI Listing
November 2018

Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor.

Hematol Oncol 2017 Sep 29;35(3):281-287. Epub 2016 Feb 29.

Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, City of Hope National Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2286DOI Listing
September 2017

Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia.

Biol Blood Marrow Transplant 2017 Feb 14;23(2):318-324. Epub 2016 Nov 14.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517662PMC
February 2017

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.

J Clin Oncol 2017 Jan 24;35(1):24-31. Epub 2016 Oct 24.

Alex F. Herrera, Matthew Mei, Lawrence Low, Joo Y. Song, Victoria Bedell, Lithua Budde, Wing C. Chan, Robert Chen, Joyce Murata-Collins, Auayporn P. Nademanee, Raju Pillai, Leslie Popplewell, Tanya Siddiqi, Jasmine Zain, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Dennis D. Weisenburger, Young Kim, Amrita Krishnan, Tanya Paris, Tracey Stiller, Joycelynne M. Palmer, City of Hope National Medical Center, Duarte, CA; Haesook T. Kim, Jennifer R. Brown, Matthew S. Davids, Arnold S. Freedman, David C. Fisher, Eric D. Jacobsen, Caron A. Jacobson, Ann S. LaCasce, David M. Weinstock, Scott J. Rodig, Philippe Armand, Dana-Farber Cancer Institute; Gabriel K. Griffin, Reid W. Merryman, Christine Pak, Heather Sun, Brigham and Women's Hospital; German A. Pihan, Beth Israel Deaconess Medical Center; and Aliyah R. Sohani, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2740DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455688PMC
January 2017

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.

J Natl Compr Canc Netw 2016 10;14(10):1274-1281

From Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Biostatistics and Data Coordinating Center, City of Hope National Medical Center, Duarte, California; Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas; Hematology and Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Medicine/Lymphoma, Memorial Sloan Kettering Cancer Center, New York, New York; and James P. Wilmot Cancer Center, University of Rochester, Rochester, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531178PMC
http://dx.doi.org/10.6004/jnccn.2016.0136DOI Listing
October 2016

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

J Natl Compr Canc Netw 2016 09;14(9):1067-79

From Memorial Sloan Kettering Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; Mayo Clinic Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; Duke Cancer Institute; Consultant; Dana-Farber/Brigham and Women's Cancer Center; Fred & Pamela Buffett Cancer Center; City of Hope Comprehensive Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; Vanderbilt-Ingram Cancer Center; UC San Diego Moores Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Alabama at Birmingham Comprehensive Cancer Center; Moffitt Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0117DOI Listing
September 2016

Allogeneic hematopoietic cell transplantation in non-Hodgkin's lymphomas.

Cancer Treat Res 2015 ;165:329-44

City of Hope National Medical Center, Hematology and Hematopoietic Cell Transplantation, 1500 East Duarte Road, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-13150-4_14DOI Listing
April 2015

Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphoma.

Biol Blood Marrow Transplant 2014 Nov 5;20(11):1864-8. Epub 2014 Jul 5.

Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.06.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194250PMC
November 2014

Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization.

Transfusion 2014 Aug 24;54(8):2015-21. Epub 2014 Mar 24.

Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, City of Hope National Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12594DOI Listing
August 2014

Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent.

Transfusion 2013 Dec 22;53(12):3244-50. Epub 2013 Apr 22.

Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, Department of Hematology, Department of Pharmacy, City of Hope National Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12198DOI Listing
December 2013

Primary cutaneous gamma-delta T-cell lymphoma with marked pagetoid epidermotropism shortly after allogeneic stem cell transplantation.

Clin Lymphoma Myeloma Leuk 2013 Dec 11;13(6):e6-9. Epub 2013 Sep 11.

Department of Pathology, City of Hope National Medical Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.05.018DOI Listing
December 2013

Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules.

Clin Breast Cancer 2013 Dec;13(6):492-5

Department of Pathology, City of Hope National Medical Center, Duarte, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2013.08.009DOI Listing
December 2013

Plerixafor plus granulocyte colony-stimulating factor improves the mobilization of hematopoietic stem cells in patients with non-Hodgkin lymphoma and low circulating peripheral blood CD34+ cells.

Biol Blood Marrow Transplant 2013 Apr 17;19(4):670-5. Epub 2013 Jan 17.

Center for Hematologic Malignancies and Adult Blood & MarrowTransplant Program, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.01.005DOI Listing
April 2013

A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation.

Biol Blood Marrow Transplant 2012 Mar 27;18(3):432-40. Epub 2011 Jul 27.

Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.07.017DOI Listing
March 2012

Acute leukemic manifestation of recurrent anaplastic large-cell lymphoma 20 years after autologous bone marrow transplantation.

J Clin Oncol 2012 Jan 12;30(3):e34-6. Epub 2011 Dec 12.

Division of Pathology, City of Hope National Medical Center, 1500 East Duarte Rd, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.37.4785DOI Listing
January 2012

High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.

Biol Blood Marrow Transplant 2011 Oct 19;17(10):1481-9. Epub 2011 Feb 19.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California 91010-3000, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791110010
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2011.02.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570567PMC
October 2011

Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma.

Ann Hematol 2011 Jul 6;90(7):803-8. Epub 2011 Jan 6.

Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-010-1146-3DOI Listing
July 2011

Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.

Oncologist 2009 ;14 Suppl 2:41-51

Hôpital Saint-Louis, Hémato-oncologie, 1 Avenue Claude Vellefaux, Paris 75010, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-S2-41DOI Listing
January 2010

Transplantation for non-Hodgkin lymphoma.

Expert Rev Hematol 2009 Aug;2(4):425-42

Division of Hematology and Hematopoietic Cell Transplantation, 1500 E. Duarte Road, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.09.24DOI Listing
August 2009

Hematopoietic stem cell transplantation for patients with advanced-stage follicular lymphoma.

J Med Assoc Thai 2008 Oct;91(10):1613-22

Division of Hematology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.

View Article

Download full-text PDF

Source
October 2008

Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.

J Clin Oncol 2008 Jan 19;26(1):90-5. Epub 2007 Nov 19.

Division of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.9248DOI Listing
January 2008

Thymoma-associated severe aplastic anemia treated with surgical resection followed by allogeneic stem-cell transplantation.

J Clin Oncol 2007 Aug;25(22):3374-5

Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.6871DOI Listing
August 2007

Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients.

Biol Blood Marrow Transplant 2007 Feb;13(2):197-205

Division of Hematology and HCT, City of Hope National Medical Center and Beckman Research Institute, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2006.09.009DOI Listing
February 2007

Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.

Biol Blood Marrow Transplant 2006 Dec;12(12):1326-34

Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California 91001, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2006.08.035DOI Listing
December 2006

Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.

Semin Hematol 2006 Oct;43(4):240-50

Division of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2006.07.006DOI Listing
October 2006

Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?

Biol Blood Marrow Transplant 2006 Jun;12(6):641-7

Division of Hematology/Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2005.12.040DOI Listing
June 2006

Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.

J Clin Oncol 2005 Sep;23(25):6163-71

City of Hope Comprehensive Cancer Center, Division of Hematology and Hematopoietic Cell Transplantation, 1500 E Duarte Rd, Duarte, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.02.774DOI Listing
September 2005

Approach to Hodgkin's lymphoma in the new millennium.

Hematol Oncol 2002 Mar;20(1):1-15

Division of Hematology/Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.683DOI Listing
March 2002